drugset / Trial / NCT00987246

Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

NCT00987246

Phase 3 Completed 470 enrolled Almirall, S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to investigate the efficacy of LAS41005 in comparison to placebo and to LAS106521 in actinic keratosis (AK).

Timeline

Start
2008-06
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator LAS106521 Unknown Topical
Subject LAS41005 Unknown Topical

Indications